Leerink Partnrs Has Negative Outlook of ELDN FY2025 Earnings
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Leerink Partnrs decreased their FY2025 earnings estimates for Eledon Pharmaceuticals in a research report issued to clients and investors on Sunday, March 23rd. Leerink Partnrs analyst T. Smith now expects that the company will post earnings per share of ($1.14) for the year, down […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Leerink Partnrs decreased their FY2025 earnings estimates for Eledon Pharmaceuticals in a research report issued to clients and investors on Sunday, March 23rd. Leerink Partnrs analyst T. Smith now expects that the company will post earnings per share of ($1.14) for the year, down […]
